Skip to page content
  • Hydrogel prevents post-infarct cardiac arrhythmia

    B85042

    Hydrogel prevents post-infarct cardiac arrhythmia

    • Injectable hydrogel integrates and matures stem cell-derived cardiomyocytes safely
    • Reduces risk of post-infarct arrhythmias
    • Validated in in vivo studies
  • The link between cardiac disease and sleepless nights

    B82005 / B83116

    The link between cardiac disease and sleepless nights

    • Underlying defective melatonin secretion in cardiac patients
    • Early anti-inflammatory intervention prevent fibrotic scarring
    • SCG hypertrophy as biomarker
  • TMEM16A inhibitors as a treatment option for cystic fibrosis

    B78025

    TMEM16A inhibitors as a treatment option for cystic fibrosis

    • TMEM16A inhibitors represent a causal treatment for cystic fibrosis
    • They reduce both excessive mucus formation and airway contraction
    • Repurposing possible: TMEM16A inhibitors include FDA-approved and well-tolerated drugs

3 of 96 Tech Offers

Interested? Get in touch!

Contact a specific team member via the Team section or simply use our contact form for your request.

Privacy settings

This website uses cookies. Cookies improve its usage and help make this website better.
Privacy policy